MedTrace Logo

Comorbidities and Risk Score in COVID-19 Patients

NCT04670094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4555

Last updated 2022-11-09

No results posted yet for this study

Summary

Retrospective multi-center cohort study. Consecutive patients hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) up to October 2020 will be included. Patients are followed until discharge from hospital or death.

Conditions

  • Covid19

Sponsors & Collaborators

  • University of Milano Bicocca

    lead OTHER

Principal Investigators

  • Maria Grazia Valsecchi, Prof. · University of Milano Bicocca

  • llaria Capua, Prof. · University of Florida

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-30
Primary Completion
2021-05-29
Completion
2021-05-29

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04670094 on ClinicalTrials.gov